Israel-based microbiome drug discovery company Biomx has announced the acquisition of biotechnology company Rondinx.

The acquisition will expand BiomX’s therapeutic pipeline and is intended to strengthen its product development pipeline.

Contract development and analytical testing laboratory Pace Analytical Services has acquired contract research organisation Wolfe Laboratories.

The acquisition enables the two companies to expand their contract drug development services to the life science industry.

Both the acquirer and target companies are based in the US.

Millendo Therapeutics has purchased Alize Pharma SAS in a stock-based transaction.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
“The $399.72m acquisition will enable JSR to expand its contract research and development capabilities.”

The target company will be renamed Millendo Therapeutics in the US and as Millendo Therapeutics SAS in France and the rest of Europe.

The acquisition enables clinical-stage biopharmaceutical company Millendo to address the unmet patient requirements in rare endocrine diseases.

Taiwanese drug discovery and development services company CrownBio has signed a merger agreement with Japanese chemical manufacturing company JSR and Gallo Merger Sub Corp.

The TWB12bn ($399.72m) acquisition will enable JSR to expand its contract research and development capabilities.

Fujifilm Corp has agreed to acquire 11.7% stake in US-based genome-editing company EdiGene Corporation through a series A investment of ¥470m ($4.17m).

The acquisition will enable the Japanese imaging and information solutions provider to manufacture gene therapy drugs.